- Home
- ATNM vs NCSM Comparison
ATNM vs NCSM Comparison
Compare ATNM & NCSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- NCSM
- Stock Information
- Founded
- ATNM 2000
- NCSM 2006
- Country
- ATNM United States
- NCSM United States
- Employees
- ATNM N/A
- NCSM N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- NCSM Oilfield Services/Equipment
- Sector
- ATNM Health Care
- NCSM Energy
- Exchange
- ATNM Nasdaq
- NCSM Nasdaq
- Market Cap
- ATNM 56.5M
- NCSM 51.9M
- IPO Year
- ATNM N/A
- NCSM 2017
- Fundamental
- Price
- ATNM $1.51
- NCSM $22.94
- Analyst Decision
- ATNM Strong Buy
- NCSM
- Analyst Count
- ATNM 5
- NCSM 0
- Target Price
- ATNM $14.20
- NCSM N/A
- AVG Volume (30 Days)
- ATNM 245.6K
- NCSM 5.0K
- Earning Date
- ATNM 11-26-2024
- NCSM 10-30-2024
- Dividend Yield
- ATNM N/A
- NCSM N/A
- EPS Growth
- ATNM N/A
- NCSM N/A
- EPS
- ATNM N/A
- NCSM 16.77
- Revenue
- ATNM $81,000.00
- NCSM $152,801,000.00
- Revenue This Year
- ATNM $186.10
- NCSM $13.26
- Revenue Next Year
- ATNM $19,248.94
- NCSM $6.32
- P/E Ratio
- ATNM N/A
- NCSM $1.37
- Revenue Growth
- ATNM 80.00
- NCSM 3.66
- 52 Week Low
- ATNM $1.33
- NCSM $12.16
- 52 Week High
- ATNM $10.24
- NCSM $23.45
- Technical
- Relative Strength Index (RSI)
- ATNM 36.23
- NCSM 72.79
- Support Level
- ATNM $1.82
- NCSM $22.21
- Resistance Level
- ATNM $1.97
- NCSM $23.45
- Average True Range (ATR)
- ATNM 0.12
- NCSM 0.87
- MACD
- ATNM -0.02
- NCSM 0.39
- Stochastic Oscillator
- ATNM 11.52
- NCSM 91.71
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About NCSM NCS Multistage Holdings Inc.
NCS Multistage Holdings Inc provides products and support services that facilitate the optimization of oil and natural gas well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's primary offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. Geographically, majority of revenue is generated from United States.